Clinical Trials Directory

Trials / Completed

CompletedNCT00067665

Hypertension in Hemodialysis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

How high blood pressure in hemodialysis patients should be diagnosed and treated using medications or without medications is the purpose of this study.

Conditions

Interventions

TypeNameDescription
OTHERUltrafiltrationAll patients participating in the trial require evaluation of dry-weight at each dialysis visit for evaluation. An initial weight loss of 0.1kg/10 kg body-weight will be prescribed per dialysis. If ultrafiltration is not tolerated based on muscle cramps, need for excessive saline or symptomatic hypotension, the intensity of ultrafiltration will be reduced by 50%. If ultrafiltration is still not tolerated, the weight loss will be further reduced by 50%. If the patient cannot tolerate at least 0.2 kg incremental weight loss per dialysis, the patient will be said to be at goal dry-weight. Thus, by this protocol, all patients must experience symptoms of volume depletion to be at dry weight.

Timeline

Start date
2003-08-01
Primary completion
2008-06-01
Completion
2008-06-01
First posted
2003-08-27
Last updated
2011-03-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00067665. Inclusion in this directory is not an endorsement.